Received by email:

File: NR Building.Final.docx

 
CSE: MDM                   FSE: 2M0                  OTCQB: MRPHF
News Release            December 21st, 2017, Kelowna, BC
Marapharm Ventures Inc. has selected American Buildings Company to build a third facility in Las Vegas, Nevada, of 65,
--->625 square feet  Marapharm Ventures Inc. "Marapharm" has selected American Builders to manufacture the third building 
--->for it's cannabis property located in Las Vegas, Nevada. Delivery is expected within 60 days. 

"American Buildings is located in Carson City Nevada and it's great that we can support a "local" manufacturer. There 
--->is the potential of a tax credit benefit because Marapharm Las Vegas LLC is also a Nevada company. American Builders i
--->s a division of Nucor Corporation which is the largest producer of steel in the United States. Quality, price, reliabi
--->lity and service was our criteria and American Buildings fits all of these items." Linda Sampson, Marapharm CEO. 

NEWS RELEASE REFERENCE

Marapharm announced on October 10, 2017 construction plans for a third building which will be 65,635 square feet on th
--->e 7 acre property located in Las Vegas, adjacent to 2 existing cultivation buildings.
The ground prep pad is ready to build on, most infrastructure is designed and in place and building plans go for bid i
--->n October 2017.
Construction will begin soon thereafter. This building is slated to be the first 3 story cannabis building in the stat
--->e of Nevada.

"Current pricing and comparable facilities in Nevada indicate that revenue from the new 3 story building will potentia
--->lly be $50 million gross and $30 million net, after operating costs, for the first year (source Kurt Keating). We will
---> be at about 20% build out with regard to the square footage of the licenses we have.  The projected revenues are esti
--->mated based on current average sales prices in the Nevada area and presumes full scale production, sales and consisten
--->t pricing in the future when the facility comes online. There is no guarantee that the new facility will achieve these
---> levels of production and sales therefrom. Marapharm is the largest marijuana license holder in Nevada." Linda Sampson
--->, CEO, Marapharm.  ABOUT MARAPHARM VENTURES INC. 
www.marapharm.com 
Marapharm is a publicly traded company primarily investing in the medical and recreational cannabis space, with corpor
--->ate operations based in British Columbia, Canada. Since 2016 they have rapidly expanded their footprint to include pro
--->duction locations in the key North American states of Washington, Nevada, and California. They actively seek expansion
---> opportunities worldwide. 
FOR FURTHER INFORMATION: 
www.marapharm.com or Linda Sampson, CEO 778-583-4476 email info@marapharm.com 
SOCIAL MEDIA: 
Facebook: facebook.com/marapharm 
Twitter: twitter.com/marapharm
Web Program: marapharm.tv
STOCK EXCHANGES: 
Marapharm trades in Canada, ticker symbol MDM on the CSE, in the United States, ticker symbol MRPHF on the OTCQB, and 
--->in Europe, ticker symbol 2Mo on the FSE. Marapharm also trades on other recognized platforms in Europe including Stutt
--->gart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin. 
Neither the CSE, the FSE nor the OTCQBtrademark has approved nor disapproved the contents of this press release. Neith
--->er the CSE, the FSE nor the OTCQBtrademark accepts responsibility for the adequacy or accuracy of this release. 
MARIJUANA INDUSTRY INVOLVEMENT: 
Canadian listings (CSE) will remain in good standing as long as they provide the disclosure that is rightly required b
--->y regulators and complying with applicable licensing requirements and the regulatory framework enacted by the applicab
--->le state in which they operate. 

Marapharm owns marijuana licenses in California and Nevada. Marijuana is legal in each state however marijuana remains
---> illegal under US federal law and the approach to enforcement of US federal law against marijuana is subject to change
--->. 
Shareholders and investors need to be aware that adverse enforcement actions could affect their investments and that M
--->arapharm's ability to access private and public capital could be affected and or could not be available to support con
--->tinuing operations. Marapharm's business is conducted in a manner consistent with state law and is in compliance with 
--->licensing requirements. 

Copies of licenses are posted on Marapharm's website. Marapharm has internal compliance procedures in place and has co
--->mpliance focused attorneys engaged in jurisdictions to monitor changes in laws for compliance with US federal and stat
--->e law on an ongoing basis. These law firms inform any necessary changes to our policies and procedures for compliance 
--->in Canada and the US. 
FORWARD - LOOKING STATEMENTS: 
Certain statements contained in this news release constitute forward looking statements. The use of any of the words "
--->anticipate", "continue", "estimate", "expect", 'may", "will", "project", "should", 'believe", and similar expressions 
--->are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties a
--->nd other factors that may cause actual results or events to differ materially from those anticipated in such forward-l
--->ooking statements are based on reasonable assumption but no assurance can be given that these expectations will prove 
--->to be correct and the forward-looking statements included in this news release should not be unduly relied upon.